Investing.com -- Moody’s Ratings has affirmed Edwards Lifesciences Corporation ’s Baa2 ratings while revising the outlook to positive from stable, the credit rating agency announced Wednesday.

The data, which will be presented at the IASLC 2025 World Conference on Lung Cancer in Barcelona, builds upon earlier results presented at ASCO. The study showed a disease control rate of 93.8% at the ...

Investing.com -- S&P Global Ratings revised its outlook on Civitas Resources Inc. to stable from positive due to the ...

Investing.com -- S&P Global Ratings has revised its outlook on KBR Inc. to negative from stable while affirming the company’s ratings, citing weaker-than-expected credit metrics. The rating agency now ...

Investing.com -- Klaviyo Inc (NYSE:KVYO) stock dropped 3.8% after the customer relationship management company announced that entities affiliated with Summit Partners would be selling 6.5 million ...

Investing.com -- Moody’s Ratings has changed EQT Corporation ’s outlook to stable from negative while affirming its Baa3 ...

Despite these challenges, Leslie’s has reduced its inventory position by 12% in Q3 2025 and expects to decrease it by over $20 million by fiscal year end. The company maintains adequate liquidity with ...

Investing.com -- Google announced plans to invest an additional $9 billion in Oklahoma over the next two years, focusing on cloud and AI infrastructure development.

Investing.com -- S&P Global Ratings has upgraded C.H. Robinson Worldwide Inc. to ’BBB+’ from ’BBB’ as the logistics company’s credit measures have significantly improved due to operational initiatives ...

CytomX indicated that the CTMX-2051-101 study is continuing, with a Phase 1 data update expected by the first quarter of 2026. The company emphasized that patient safety remains its top priority as it ...

Investing.com -- Traders are now pricing in a 99% probability of a 25-bps interest rate cut at the September 17, 2025, Federal Reserve meeting, according to Investing.com’s Fed Rate Monitor Tool. This ...

For the first half of 2025, Fidelis reported a net loss of $22.8 million, or $ (0.21) per diluted share, compared to net income of $134.9 million, or $1.14 per diluted share, in the first half of 2024 ...